4 Life Sciences Companies Launch IPOs Totaling $588M
Four life sciences companies, including three U.S. firms developing therapies to treat cancer and other maladies plus a Chinese cancer diagnostics provider, set price ranges Monday for initial public offerings estimated...To view the full article, register now.
Already a subscriber? Click here to view full article